Sio Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sio Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,000	Closed	-$3.19M	–	66
2022 Q2	$3.19M	Buy	+40,000	New	+$3.79M	1.2%	25
2022 Q1	–	Sell	-29,319	Closed	-$3.16M	–	86
2021 Q4	$3.16M	Hold	29,319	–	–	0.95%	28
2021 Q3	$3.21M	Sell	29,319 -38,152	-57%	-$3.96M	1.02%	32
2021 Q2	$6.32M	Buy	67,471 +2,670	+4%	+$246K	1.57%	18
2021 Q1	$5.96M	Sell	64,801 -34,100	-34%	-$2.88M	1.21%	29
2020 Q4	$7.24M	Sell	98,901 -48,599	-33%	-$3.61M	1.48%	21
2020 Q3	$11.5M	Buy	+147,500	New	+$10.1M	2.27%	16

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Sio Capital Management's HZNP Position: Q3 2022 in Review

Sio Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 40,000 shares — an estimated $3.19M sold.

Sio Capital Management first reported a position in HZNP in Q3 2020 and held it in 7 quarters. The position peaked at $11.5M in Q3 2020. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Sio Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Sio Capital Management sold 40,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $3.19M.
Sio Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 7 quarters.
Sio Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $11.5M in Q3 2020.
529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.